SCHEMBL9308909

SCHEMBL9308909

CCCc1nc(C)n2c(=O)[nH]nc2c1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9311058 0.95 AGTR1 (0.49) AGTR1
SCHEMBL9310307 0.89 AGTR1 (0.46) AGTR1
SCHEMBL9310578 0.85 AGTR1 (0.49) AGTR1
Ripisartan SCHEMBL489673 0.84 AGTR1 (0.73) AGTR1
SCHEMBL9309079 0.83 AGTR1 (0.48) AGTR1
SCHEMBL9308719 0.83 AGTR1 (0.50) AGTR1
SCHEMBL9308164 0.82
SCHEMBL9308556 0.82 AGTR1 (0.49) AGTR1
SCHEMBL9309186 0.81 AGTR1 (0.49) AGTR1
SCHEMBL9309068 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5358950-A Useful in treatment of cardiovascular diseases LABORATOIRES UPSA (FR) 1994-10-25 US claimed
US-5358950-A Useful in treatment of cardiovascular diseases LABORATOIRES UPSA (FR) 1994-10-25 US disclosed